Advertisement

Topics

BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP Company Profile

00:46 EST 24th November 2017 | BioPortfolio


News Articles [62 Associated News Articles listed on BioPortfolio]

Berger's disease treatment gains orphan status

The FDA gave orphan designation to Anthera Pharmaceuticals' blisibimod to treat immunoglobulin A nephropathy, or Berger's dis -More- 

FDA gives orphan status to Omeros' Berger's disease drug

Omeros' breakthrough therapy OMS721, indicated to treat patients with the kidney disorder Berger's disease, has been granted  -More- 

Bernstein hebt Ziel für Novartis auf 94 Franken - 'Outperform'

Das US-Analysehaus Bernstein Research hat das Kursziel für Novartis von 86 auf 94 Franken angehoben und die Einstufung auf "Outperform" belassen. Der Pharmakonzern sei einer seiner bevorzugten Tit...

Bernstein belässt McDonalds auf 'Outperform' - Ziel 180 US-Dollar

Das US-Analysehaus Bernstein Research hat die Einstufung für die Aktien der Schnellrestaurantkette McDonalds auf "Outperform" mit einem Kursziel von 180 US-Dollar belassen. Dies schrieb Analystin ...

Bernstein belässt Pfizer auf 'Outperform' - Ziel 39 US-Dollar

Das US-Analysehaus Bernstein Research hat die Einstufung für die Aktien des Pharmakonzerns Pfizer auf "Outperform" mit einem Kursziel von 39 US-Dollar belassen. Dies schrieb Analyst Tim Anderson i...

Bernstein hebt Ziel für Apple auf 170 US-Dollar - 'Outperform'

Das US-Analysehaus Bernstein Research hat das Kursziel für Apple vor Zahlen zum dritten Geschäftsquartal von 160 auf 170 US-Dollar angehoben und die Einstufung auf "Outperform" belassen. Die Resul.....

Bernstein belässt Roche auf 'Outperform' - Ziel 284 Franken

Das US-Analysehaus Bernstein Research hat die Einstufung für Roche nach Zahlen auf "Outperform" mit einem Kursziel von 284 Franken belassen. Auf den ersten Blick habe der Schweizer Pharmakonzerns ...

Bernstein hebt Ziel für Novartis auf 97 Franken - 'Outperform'

Das US-Analysehaus Bernstein Research hat das Kursziel für Novartis nach Zahlen zum dritten Quartal von 95 auf 97 Franken angehoben und die Einstufung auf "Outperform" belassen. Der Schweizer Phar...

Drugs and Medications [0 Results]

None

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Two new combinations, lectotypifications and a new name for Costa Rican Palicourea s.l.

Species of the complex and diverse genera Psychotria and Palicourea are common but little-known elements in many tropical forest ecosystems. DNA-phylogenetic studies and a re-evaluation of morphologic...

Morphogenesis and molecular phylogeny of the soil ciliate Rigidohymena quadrinucleata (Dragesco and Njine, 1971) Berger, 2011 (Ciliophora, Hypotricha, Oxytrichidae).

Morphogenesis in the soil hypotrich ciliate, Rigidohymena quadrinucleata (Dragesco and Njine, 1971) Berger, 2011; was investigated using protargol staining. The main events during binary fission are a...

Analysis of metabolomic profile of fermented Orostachys japonicus A. Berger by capillary electrophoresis time of flight mass spectrometry.

Microbial cell performance in food biotechnological processes has become an important concern for improving human health worldwide. Lactobacillus plantarum, which is widely distributed in nature, is a...

500 Years of Reformation: The History of Martin Luther's Pathography and its Ethical Implications.

Introduction In the context of the 500th anniversary of the Reformation, it is time to take a survey of the history of Martin Luther's (1483-1546) pathography and to deduce possible conclusions from i...

Morphogenesis of a saline soil ciliate Urosoma salmastra (Dragesco and Dragesco-Kernéis, 1986) Berger, 1999 with notes on the phylogeny of Urosoma (Ciliophora, Hypotrichia).

Morphogenesis in a population of Urosoma salmastra collected from saline soil in Weinan, China, was investigated using protargol staining. The main morphogenetic event that characterizes U. salmastra ...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Computed Tomography (CT) Score and Histopathology of the Middle Turbinate in Chronic Rhinosinusitis

In a previous study (Berger el al. Old and new aspects of middle turbinate histopathology. Otolaryngol Head Neck Surg. 2009;140:48-54), the investigators reported significant histopatholog...

Assessment of Cardiac Autonomic Function in Adulthood After Chemotherapy or Radiotherapy in Childhood

The SALTO-SNA study is an ancillary study of the SALTO study (Suivi À Long Terme en Oncologie des enfants guéris d'un cancer pédiatrique en régions Rhône-Alpes et Auvergne) coordinate...

GERD and Anti-Reflux Therapy in Persons With SCI

Respiratory dysfunction, esophageal dysmotility, and a gastroesophageal reflux disease (GERD) have been demonstrated to be highly prevalent in persons with SCI. GERD has been linked to res...

The Effect of Acute Tryptophan Depletion (ATD) on Esophageal Sensitivity in Healthy Volunteers

Esophageal hypersensitivity is considered an important pathophysiological mechanism in patients suffering form non-erosive gastro-esophageal reflux disease. Serotonin (5-HT) is predominant...

Companies [15 Associated Companies listed on BioPortfolio]

BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP

Greenblum & Bernstein PLC

"Greenblum & Bernstein, P.L.C. is a patent law company located close to Washington D.C., and enforces intellectual property rights for many of the worlds leading companies.Greenblum & Bernstein, P.L.C...

Lieff, Cabraser, Heimann & Bernstein, LLP

Lieff Cabraser Heimann & Bernstein, LLP, represents persons across America injured by defective medical devices, including the DePuy ASR artificial hip.

Lieff Cabraser Heimann & Bernstein, LLP

Lieff Cabraser Heimann & Bernstein, LLP is a sixty-plus attorney law firm that has represented plaintiffs nationwide since 1972. With offices in New York, San Francisco, and Nashv...

Lieff Cabraser Heimann & Bernstein, LLP The incorrect sentence goes here

Recognized as "one of the nation's premier plaintiff's firms," Lieff Cabraser Heimann & Bernstein, LLP is a sixty-plus attorney law firm with offices in San Francisco, New York an...

More Information about "BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP" on BioPortfolio

We have published hundreds of BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP news stories on BioPortfolio along with dozens of BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP Clinical Trials and PubMed Articles about BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP Companies in our database. You can also find out about relevant BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record